Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.30 |
| ▸ | EDNRB | P24530 | 1/20 | 0.30 |
| ▸ | EDNRA | P25101 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8762239 | 0.83 | ALDH1A1 (0.41) | ALDH1A1CES1MAPT | |
| SCHEMBL21459542 | 0.83 | NCEH1 (0.37) | ALDH1A1CES1MAPTMEN1KMT2A | |
| SCHEMBL4975220 | 0.83 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL31636541 | 0.79 | ALDH1A1 (0.48) | ALDH1A1MEN1KMT2A | |
| SCHEMBL21050679 | 0.79 | ALDH1A1 (0.48) | ALDH1A1MEN1KMT2A | |
| SCHEMBL23226962 | 0.79 | CYP3A4 (0.42) | ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL15476296 | 0.79 | CYP3A4 (0.42) | ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL15497515 | 0.79 | RAPGEF4 (0.32) | MEN1KMT2A | |
| SCHEMBL10989519 | 0.79 | ALDH1A1 (0.48) | ALDH1A1MEN1KMT2A | |
| SCHEMBL6681654 | 0.77 | ALDH1A1 (0.48) | ALDH1A1CES1MAPTCYP1A2CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109761787-A | The preparation method of the chloro- 2 bromo toluene of 3,6- bis- and the preparation method of dicamba | 山东润博生物科技有限公司 | 2019-05-17 | — | — | CN | claimed |
| US-10442990-B2 | Mesogenic compounds, liquid crystal media and components for high frequency technology | MERCK PATENT GMBH (DE) | 2019-10-15 | — | — | US | disclosed |
| CN-109761787-A | The preparation method of the chloro- 2 bromo toluene of 3,6- bis- and the preparation method of dicamba | 山东润博生物科技有限公司 | 2019-05-17 | — | — | CN | disclosed |
| US-9938462-B2 | Liquid-crystalline media, components for high-frequency technology, and mesogenic compounds | MERCK PATENT GMBH (DE) | 2018-04-10 | — | — | US | disclosed |
| US-9765259-B2 | Mesogenic compounds, liquid-crystalline media and components for high-frequency technology | MERCK PATENT GMBH (DE) | 2017-09-19 | — | — | US | disclosed |
| US-9752077-B2 | Liquid-crystalline media, components for high-frequency technology, and mesogenic compounds | MERCK PATENT GMBH (DE) | 2017-09-05 | — | — | US | disclosed |
| US-9605204-B2 | Liquid crystal medium and high frequency components comprising same | MERCK PATENT GMBH (DE) | 2017-03-28 | — | — | US | disclosed |
| US-9523037-B2 | Liquid-crystalline media, components for high-frequency technology, and mesogenic compounds | MERCK PATENT GMBH (DE) | 2016-12-20 | — | — | US | disclosed |
| US-9296948-B2 | Mesogenic compounds, liquid-crystalline media and components for high-frequency technology | MERCK PATENT GMBH (DE) | 2016-03-29 | — | — | US | disclosed |
| US-20160002533-A1 | LIQUID-CRYSTALLINE MEDIA, COMPONENTS FOR HIGH-FREQUENCY TECHNOLOGY, AND MESOGENIC COMPOUNDS | MERCK PATENT GMBH (DE) | 2016-01-07 | — | — | US | disclosed |
| US-20150322344-A1 | LIQUID-CRYSTALLINE MEDIA, COMPONENTS FOR HIGH-FREQUENCY TECHNOLOGY, AND MESOGENIC COMPOUNDS | MERCK PATENT GMBH (DE) | 2015-11-12 | — | — | US | disclosed |
| US-8999198-B2 | Compounds for a liquid-crystalline medium, and the use thereof for high-frequency components | MERCK PATENT GMBH (DE) | 2015-04-07 | — | — | US | disclosed |
| US-20140021409-A1 | MESOGENIC COMPOUNDS, LIQUID-CRYSTALLINE MEDIA AND COMPONENTS FOR HIGH-FREQUENCY TECHNOLOGY | MERCK PATENT GMBH (DE) | 2014-01-23 | — | — | US | disclosed |
| US-20140021405-A1 | MESOGENIC COMPOUNDS, LIQUID-CRYSTALLINE MEDIA AND COMPONENTS FOR HIGH-FREQUENCY TECHNOLOGY | MERCK PATENT GMBH (DE) | 2014-01-23 | — | — | US | disclosed |
| US-20130221274-A1 | COMPOUNDS FOR A LIQUID-CRYSTALLINE MEDIUM, AND THE USE THEREOF FOR HIGH-FREQUENCY COMPONENTS | MERCK PATENT GMBH (DE) | 2013-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150322344-A1 | LIQUID-CRYSTALLINE MEDIA, COMPONENTS FOR HIGH-FREQUENCY TECHNOLOGY, AND MESOGENIC COMPOUNDS | MIF, SFRP1, MCM3 | ALDH1A1 4410/4885CES1 4770/4885MAPT 709/4885 |
| US-20130221274-A1 | COMPOUNDS FOR A LIQUID-CRYSTALLINE MEDIUM, AND THE USE THEREOF FOR HIGH-FREQUENCY COMPONENTS | CRY1, WIZ, HCN3 | ALDH1A1 3044/4885CES1 3674/4885MAPT 2664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.